2024 asa guidance glp-1 receptor agonists perioperative management of patients taking glucagon-like peptide 1 agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement A very important and practice-changing

- **Slow digestion:** Delaying stomach emptying to prevent spikes in sugar levels after meals

SAN DIEGO(March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

SUGGESTED USE: Adults take 1 capsule daily, or as recommended by your healthcare practitioner, with 8 ounces of water or your favorite beverage

This unique formula activates GLP-1 and CB2 receptors to help reduce appetite, promote faster and longer-lasting fullness, support healthy glucose metabolism and craving control, and enhance mood and energy levels

Type 2 diabetes represents a growing challenge for global public health

Clinical trials, brain mechanisms, and real-world data reveal a complex picture